RNA-Guided Recombinase-Cas9 Fusion Targets Genomic DNA Deletion and Integration-Reference-Cited by-同舟云学术

RNA-Guided Recombinase-Cas9 Fusion Targets Genomic DNA Deletion and Integration

Published:2019-08-01 Issue:4 Volume:2 Page:209-222
ISSN:2573-1599
Container-title:The CRISPR Journal
language:en
Short-container-title:The CRISPR Journal

Author:

Standage-Beier Kylie¹²,Brookhouser Nicholas¹³,Balachandran Parithi¹,Zhang Qi¹,Brafman David A.¹,Wang Xiao¹

Affiliation:

1. School of Biological and Health Systems Engineering and University of Arizona College of Medicine–Phoenix, Phoenix, Arizona.

2. Molecular and Cellular Biology Graduate Program, Arizona State University, Tempe, Arizona; University of Arizona College of Medicine–Phoenix, Phoenix, Arizona.

3. Graduate Program in Clinical Translational Sciences, University of Arizona College of Medicine–Phoenix, Phoenix, Arizona.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Biotechnology

Link

https://www.liebertpub.com/doi/pdf/10.1089/crispr.2019.0013

Reference51 articles.

1. Multiplex Genome Engineering Using CRISPR/Cas Systems

2. RNA-Guided Human Genome Engineering via Cas9

3. Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System

4. CRISPR-Cas systems for editing, regulating and targeting genomes

5. May I Cut in? Gene Editing Approaches in Human Induced Pluripotent Stem Cells

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genome editing and its role in vaccine, diagnosis, and therapeutic advancement;International Journal of Biological Macromolecules;2024-06

2. Systematic Development of Reprogrammed Modular Integrases Enables Precise Genomic Integration of Large DNA Sequences;2024-05-10

3. Recent advances in CRISPR-Cas9-based genome insertion technologies;Molecular Therapy - Nucleic Acids;2024-03

4. Activation of recombinases at specific DNA loci by zinc-finger domain insertions;Nature Biotechnology;2024-01-31

5. Long sequence insertion via CRISPR/Cas gene-editing with transposase, recombinase, and integrase;Current Opinion in Biomedical Engineering;2023-12